INMODE LTD (INMD)
IL0011595993 - Common Stock
INMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. INMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. INMD is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make INMD suitable for value and quality investing!
1. Profitability
1.1 Basic Checks
INMD had positive earnings in the past year.
In the past year INMD had a positive cash flow from operations.
INMD had positive earnings in each of the past 5 years.
Each year in the past 5 years INMD had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 22.92%, INMD belongs to the best of the industry, outperforming 98.96% of the companies in the same industry.
With an excellent Return On Equity value of 25.13%, INMD belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
INMD has a better Return On Invested Capital (20.97%) than 98.44% of its industry peers.
INMD had an Average Return On Invested Capital over the past 3 years of 28.25%. This is significantly above the industry average of 8.53%.
The 3 year average ROIC (28.25%) for INMD is well above the current ROIC(20.97%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.92% | ||
| ROE | 25.13% | ||
| ROIC | 20.97% |
ROA(3y)27.49%
ROA(5y)27.16%
ROE(3y)31.31%
ROE(5y)31.63%
ROIC(3y)28.25%
ROIC(5y)27.22%
1.3 Margins
INMD has a Profit Margin of 40.21%. This is amongst the best in the industry. INMD outperforms 99.48% of its industry peers.
In the last couple of years the Profit Margin of INMD has grown nicely.
Looking at the Operating Margin, with a value of 39.76%, INMD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
INMD's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 83.59%, INMD belongs to the best of the industry, outperforming 94.27% of the companies in the same industry.
INMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.76% | ||
| PM (TTM) | 40.21% | ||
| GM | 83.59% |
OM growth 3Y4.03%
OM growth 5Y4.81%
PM growth 3Y3.39%
PM growth 5Y12.47%
GM growth 3Y-0.57%
GM growth 5Y-0.32%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INMD is creating value.
Compared to 1 year ago, INMD has more shares outstanding
Compared to 5 years ago, INMD has more shares outstanding
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 15.06 indicates that INMD is not in any danger for bankruptcy at the moment.
The Altman-Z score of INMD (15.06) is better than 92.19% of its industry peers.
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 15.06 |
ROIC/WACC2.33
WACC9.01%
2.3 Liquidity
A Current Ratio of 13.18 indicates that INMD has no problem at all paying its short term obligations.
INMD's Current ratio of 13.18 is amongst the best of the industry. INMD outperforms 95.83% of its industry peers.
A Quick Ratio of 12.48 indicates that INMD has no problem at all paying its short term obligations.
INMD's Quick ratio of 12.48 is amongst the best of the industry. INMD outperforms 95.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.18 | ||
| Quick Ratio | 12.48 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.35% over the past year.
The Earnings Per Share has been growing by 45.76% on average over the past years. This is a very strong growth
INMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.34%.
Measured over the past years, INMD shows a very strong growth in Revenue. The Revenue has been growing by 37.48% on average per year.
EPS 1Y (TTM)5.35%
EPS 3Y34.38%
EPS 5Y45.76%
EPS growth Q2Q-8.97%
Revenue 1Y (TTM)8.34%
Revenue growth 3Y33.65%
Revenue growth 5Y37.48%
Revenue growth Q2Q-5.1%
3.2 Future
Based on estimates for the next years, INMD will show a small growth in Earnings Per Share. The EPS will grow by 4.47% on average per year.
The Revenue is expected to grow by 5.67% on average over the next years.
EPS Next Y1.6%
EPS Next 2Y3.76%
EPS Next 3Y4.47%
EPS Next 5YN/A
Revenue Next Year1.73%
Revenue Next 2Y4.78%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 6.78 indicates a rather cheap valuation of INMD.
INMD's Price/Earnings ratio is rather cheap when compared to the industry. INMD is cheaper than 98.44% of the companies in the same industry.
When comparing the Price/Earnings ratio of INMD to the average of the S&P500 Index (28.06), we can say INMD is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.67, the valuation of INMD can be described as very cheap.
Based on the Price/Forward Earnings ratio, INMD is valued cheaper than 98.96% of the companies in the same industry.
INMD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.72.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.78 | ||
| Fwd PE | 6.67 |
4.2 Price Multiples
INMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INMD is cheaper than 98.96% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INMD is valued cheaply inside the industry as 98.96% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.34 | ||
| EV/EBITDA | 1.75 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.23
PEG (5Y)0.15
EPS Next 2Y3.76%
EPS Next 3Y4.47%
5. Dividend
5.1 Amount
INMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INMODE LTD
NASDAQ:INMD (5/2/2024, 7:00:18 PM)
After market: 17.4 +0.04 (+0.23%)17.36
+0.12 (+0.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.47B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.78 | ||
| Fwd PE | 6.67 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.23
PEG (5Y)0.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.92% | ||
| ROE | 25.13% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 39.76% | ||
| PM (TTM) | 40.21% | ||
| GM | 83.59% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 13.18 | ||
| Quick Ratio | 12.48 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)5.35%
EPS 3Y34.38%
EPS 5Y
EPS growth Q2Q
EPS Next Y1.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.34%
Revenue growth 3Y33.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y